These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16426111)

  • 1. Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders.
    Keck PE; Strawn JR; McElroy SL
    J Clin Psychiatry; 2006; 67 Suppl 1():8-15. PubMed ID: 16426111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review.
    Rakofsky JJ; Dunlop BW
    J Clin Psychiatry; 2011 Jan; 72(1):81-90. PubMed ID: 21208580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and management of anxiety in patients with bipolar disorder.
    Kauer-Sant'Anna M; Kapczinski F; Vieta E
    CNS Drugs; 2009 Nov; 23(11):953-64. PubMed ID: 19845416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN; Stein MB
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbid anxiety in bipolar disorder alters treatment and prognosis.
    El-Mallakh RS; Hollifield M
    Psychiatr Q; 2008 Jun; 79(2):139-50. PubMed ID: 18491230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.
    Singh JB; Zarate CA
    Bipolar Disord; 2006 Dec; 8(6):696-709. PubMed ID: 17156156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bipolar disorders and comorbid anxiety: prognostic impact and therapeutic challenges].
    Cazard F; Ferreri F
    Encephale; 2013 Feb; 39(1):66-74. PubMed ID: 23095585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
    Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
    Simon NM; Otto MW; Weiss RD; Bauer MS; Miyahara S; Wisniewski SR; Thase ME; Kogan J; Frank E; Nierenberg AA; Calabrese JR; Sachs GS; Pollack MH;
    J Clin Psychopharmacol; 2004 Oct; 24(5):512-20. PubMed ID: 15349007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder.
    Kim SW; Berk L; Kulkarni J; Dodd S; de Castella A; Fitzgerald PB; Amminger GP; Berk M
    J Affect Disord; 2014 Sep; 166():243-8. PubMed ID: 25012437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of atypical antipsychotics in bipolar depression and anxiety disorders.
    McIntyre R; Katzman M
    Bipolar Disord; 2003; 5 Suppl 2():20-35. PubMed ID: 14700010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
    Suppes T; McElroy SL; Sheehan DV; Hidalgo RB; Cosgrove VE; Gwizdowski IS; Feldman NS
    J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues.
    Freeman MP; Freeman SA; McElroy SL
    J Affect Disord; 2002 Feb; 68(1):1-23. PubMed ID: 11869778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.